MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series D
Oxyrane, Ltd
Parents
*Industry: Netherlands
Venture Capital: Series D
Children
Clinical-stage biopharmaceutical focused on enzyme replacement therapies for Pompe’s a lysosomal storage disease, Oxyrane, Ltd
Participants include Forbion Capital Partners, Morningside Group and New Science Ventures
Series D $26.5M by OnBioVC (2012)